Table: Modalis Therapeutics -2025 group results

Modalis Therapeutics

12/02/2026 06:45

Feb 12 (Reuters)- 
          Modalis Therapeutics Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Operating     loss 2.21       loss 1.34                              
  Recurring     loss 2.15       loss 1.30                              
  Net
  Net           loss 2.15       loss 1.32                              
  EPS        loss 27.86 yen  loss 28.57 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Modalis Therapeutics Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T